This session examines where the inefficiencies are, what's actually changing, and what a best-in-class development program looks like today. The adoption gap is just as important: designing a trial without thinking about how the product will be used in practice builds in a commercialization problem from day one.
- Where the biggest time and cost sinks in trial design are structural versus fixable
- Real-world evidence and PIMS data as a supplement to traditional clinical trials
- What regulators, acquirers, and licensees actually need from your data package
- Designing for adoption: building clinical utility and practice-readiness from the start
- The CRO landscape: what's available, what's missing, and where the bottlenecks are
Speaker(s):

Cheryl London
Director of Clinical Research
Tufts University, Cummings School of Veterinary Medicine

Tommy Jackson
Chief Executive Officer
Prelude

Linda Black
Chief Executive Officer
Gallant
Time:
3:50pm-4:20pm
Agenda Track No.:
Track 8
Session Type:
General Session (Presentation)
Force Inline Description:
0